1 mg/kg GR-MD-02
14-004A
Phase 1 mab completed
Quick answer
1 mg/kg GR-MD-02 for Metastatic Melanoma is a Phase 1 program (mab) at GALECTIN THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GALECTIN THERAPEUTICS INC
- Indication
- Metastatic Melanoma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed